massimo fusconi

Prof. massimo fusconi


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2014 in Autoimmunity Reviews
Verified
Journal Article
Closed access
Antonio GrecoAntonio Greco
Antonio Greco
AVArmando De Virgilio
Armando De Virgilio
AGAndrea Gallo
Andrea Gallo
MFmassimo fusconi
massimo fusconi
RTRosaria Turchetta
Rosaria Turchetta
MVMarco De Vincentiis
Marco De Vincentiis

22 August 2012 in International Journal of Audiology
Verified
Journal Article
Closed access
MFmassimo fusconi
massimo fusconi
ACAntonio Chistolini
Antonio Chistolini
AVArmando De Virgilio
Armando De Virgilio
Antonio GrecoAntonio Greco
Antonio Greco
FMFulvio Massaro
Fulvio Massaro
MVMarco de Vincentiis
Marco de Vincentiis
Objective: This aim of this study was to determine the prevalence of thrombophilic risk factors in sudden sensorineural hearing loss, central retinal vein occlusion, and stroke associated with small vessel disease, with the purpose of investigating and reinforcing the vascular hypothesis in the pathogenesis of sudden sensorineural hearing loss. Design: Case-control study. Genetic and acquired risk factors of these three groups were compared with healthy controls. Study sample: Forty-nine, 60, and 101 patients affected respectively by sudden sensorineural hearing loss, central retinal vein occlusion, or stroke associated with small vessel disease, enrolled during a three-year period were compared with 210 healthy controls. Results: The frequency of hyperhomocysteinemia (homocysteine ≥ 15 μmol/L) was higher in each disease group than in controls. A statically significant, albeit weak, correlation between the MTHFR C677T mutation and hyperhomocysteinemia was found in all three diseases. Conclusions: Hyperhomocysteinemia proved to be a risk factor for sudden sensorineural hearing loss. Based on these results, we propose to analyse homocysteine in sudden sensorineural hearing loss patients and, if its values are high, to evaluate the presence of MTHFR C677T mutation.

12 January 2016 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
MFmassimo fusconi
massimo fusconi
VPVincenzo Petrozza
Vincenzo Petrozza
SSSerena Schippa
Serena Schippa
MVMarco de Vincentiis
Marco de Vincentiis
GFGiuseppe Familiari
Giuseppe Familiari
AGAndrea Gallo
Andrea Gallo

1 August 2009 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
MFmassimo fusconi
massimo fusconi
GBGuido Benfari
Guido Benfari
Franco MazzeiFranco Mazzei
Franco Mazzei
DDDaniela Deriu
Daniela Deriu
FDFerdinando Dambrosio
Ferdinando Dambrosio
MVMarco de Vincentiis
Marco de Vincentiis

1 March 2017 in Journal of Voice
Verified
Journal Article
Closed access
MFmassimo fusconi
massimo fusconi
FCflaminia campo
flaminia campo
AGAndrea Gallo
Andrea Gallo
GZGiampietro Zambetti
Giampietro Zambetti
SMSalvatore Martellucci
Salvatore Martellucci
MVMarco de Vincentiis
Marco de Vincentiis

25 August 2010 in Audiology and Neurotology
Verified
Journal Article
Closed access
MFmassimo fusconi
massimo fusconi
ACAntonio Chistolini
Antonio Chistolini
NANoemi Angelosanto
Noemi Angelosanto
PPPatrizia Pignoloni
Patrizia Pignoloni
MTMario Tombolini
Mario Tombolini
MVMarco de Vincentiis
Marco de Vincentiis
The methylenetetrahydrofolate reductase C677T mutation, factor V G1691A (factor V Leiden) mutation, prothrombin G20210A mutation and 8 other laboratory values associated with increased thrombotic risk were analyzed in 40 patients with sudden sensorineural hearing loss (SSHL). The results were compared with those obtained from 120 controls not affected by SSHL. We found a statistically significant higher frequency of hyperhomocysteinemia in the SSHL group compared with controls, and that this was also associated with the presence of homozygosity for the MTHFR C677T mutation. The study results suggest that SSHL might be caused, among other factors, by a combination of these 2 variables. We suggest that this analysis of the MTHFR C677T mutation should be further investigated to establish the etiology of SSHL, and that the same analysis should be taken into account in those patients with high levels of homocysteine.